This program is designed to assist health care providers improve their pulmonary disease education knowledge and skill in an effort to improve long-term pulmonary disease care and improve patient quality of life. At the conclusion of this program, the participant will be able to identify key components of pulmonary disease education and apply their knowledge to the education and management of patients with COPD, asthma, pulmonary fibrosis, cystic fibrosis, lung cancer, and pulmonary hypertension.

Criteria for successful completion includes viewing all course videos in their entirety as well as scoring 70% or higher on the post-course test.

This course is approved by the AARC for 14.5 CRCE.

This course is approved by the Ohio Nurses Association through 12/8/2018. (ONA #20423) The Ohio Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

The AARC produced this educational course with support from the following organizations:

 

Seminar Information
Seminar Date:
November 15, 2016
Expiration Date:
December 31, 2017 11:55 PM
Seminar Objectives
  • Pathophysiology and Assessment of COPD: Explain the pathophysiology of COPD; describe the methods of COPD diagnosis; identify treatment strategies for COPD; and describe components of assessment for a patient with COPD
  • Pathophysiology and Assessment of Asthma: Explain the pathophysiology of asthma; describe the methods of asthma diagnosis; identify treatment strategies for asthma; and describe components of assessment for a patient with asthma
  • Pathophysiology and Assessment of Cystic Fibrosis: Explain the pathophysiology of cystic fibrosis; describe the methods of cystic fibrosis diagnosis; identify treatment strategies for cystic fibrosis; and describe components of assessment for a patient with cystic fibrosis
  • Pathophysiology and Assessment of Lung Cancer: Explain the pathophysiology of lung cancer; describe the methods of lung cancer diagnosis; identify treatment strategies for lung cancer; and describe components of assessment for a patient with lung cancer
  • Pathophysiology and Assessment of Interstitial Lung Disease: Explain the pathophysiology of interstitial lung disease; describe the methods of interstitial lung disease; identify treatment strategies for interstitial lung disease; and describe components of assessment for a patient with interstitial lung disease
  • Pathophysiology and Assessment of Pulmonary Hypertension: Explain the pathophysiology of pulmonary hypertension; describe the methods of pulmonary hypertension diagnosis; identify treatment strategies for pulmonary hypertension; and describe components of assessment for a patient with pulmonary hypertension
  • Overview of Disease Management: Identify the key components to a comprehensive disease management program; describe the importance of and the barriers to patient self-management; and identify the skills necessary to be an effective disease manager
  • Pulmonary Function Testing: Define three types of pulmonary function tests; review reference equations/predicted values/lower limits of normal; describe quality testing criteria; describe and review lung volumes and capacities; identify specific pulmonary abnormalities with pulmonary function tests; and identify disease severity with pulmonary function tests
  • Pharmacologic Interventions: List currently available pulmonary medications; describe indications for various pulmonary medications based on scientific evidence and use in specific disease processes; and determine appropriate delivery method for inhaled medications based on patient cognition, physical ability, and preference
  • Supplemental Oxygen Administration: Describe the physiological benefit of supplemental oxygen; differentiate between various home oxygen delivery systems; anddetermine appropriate delivery system to meet patient need
  • Tobacco Cessation: Explain the scientific factors supporting tobacco cessation; identify general approaches to smoking cessation; explain the pharmacologic agents employed in a tobacco cessation program; identify the barriers to tobacco cessation; describe motivational interviewing; and demonstrate effective motivational interviewing skills.
  • Exacerbation Management: Identify respiratory changes that indicate the presence of a pulmonary disease exacerbation; recognize the severity level of an exacerbation; and determine appropriate interventions for various severity levels of exacerbations
  • Nutrition for the Patient with Pulmonary Disease: Describe the measurement of malnutrition; describe the effects of malnutrition on patients with pulmonary disease; and develop a nutrition strategy for patients with pulmonary disease
  • Lung Transplantation: Identify the qualifying measures for listing a patient for lung transplantation; discuss the self-management behaviors necessary for maintaining status on the transplantation list; discuss the challenges in adhering to a pre-lung transplantation program; identify the health behaviors necessary for wellness post-transplantation; and discuss the role of the health care provider in assisting the patient post-transplant
  • Palliative Care and Chronic Pulmonary Disease: Differentiate between palliative care and hospice; identify appropriate timing to initiate hospice; and discuss palliative care in the context of chronic lung disease
  • Pulmonary Rehabilitation: Define pulmonary rehabilitation; describe the essential components of a comprehensive pulmonary rehabilitation program; and explain the benefits of pulmonary rehabilitation
  • Discharge Planning: Name the 5 key standards in the Discharge Planning Hospital Conditions of Participation; describe one or two elements of each standard; name the Medicare requirements for reimbursement of commonly ordered respiratory DME; and describe key roles in improving transitions.
  • Patient Education: Identify essential components of effective communication and patient education; describe basic adult learning theory; identify barriers to learning; discuss issues with transitional care
  • Measurable Outcomes in a Chronic Pulmonary Disease Management Program: Discuss the importance of measuring outcomes to the success of the chronic disease management program; identify meaningful outcomes measures; and discuss reimbursement
Introduction to the AARC Pulmonary Disease Educator Course

This video introduces the learner to the AARC Pulmonary Disease Educator course.

This video is approximately 3 minutes in length.

Pathophysiology and Assessment of Chronic Obstructive Pulmonary Disease

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of COPD.

At the end of this presentation, the participant will be able to:

  1. Explain the pathophysiology of COPD
  2. Describe the methods of COPD diagnosis
  3. Identify treatment strategies for COPD
  4. Describe components of assessment for a patient with COPD

The presenter discloses relationships with Boehringer Ingelheim, Novartis, GlaxoSmithKline, and Astra Zeneca.

This video is approximately 49 minutes in length.

This presentation is sponsored by 


 

Speaker Information
Richard Casaburi MD, MEng, PhD  [ view bio ]
Pathophysiology and Assessment of Asthma

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of asthma.

At the end of this presentation, the participant will be able to:

  1. Explain the pathophysiology of asthma
  2. Describe the methods of asthma diagnosis
  3. Identify treatment strategies for asthma
  4. Describe components of assessment for a patient with asthma

The presenter has no relationships to disclose.

This video is approximately 60 minutes in length.

This presentation is sponsored by 

 

Speaker Information
Bradley Chipps MD  [ view bio ]
Pathophysiology and Assessment of Cystic Fibrosis

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of cystic fibrosis.

At the end of this presentation, the participant will be able to:

  1. Explain the pathophysiology of cystic fibrosis
  2. Describe the methods of cystic fibrosis diagnosis
  3. Identify treatment strategies for cystic fibrosis
  4. Describe components of assessment for a patient with cystic fibrosis

The presenter discloses relationships with Chiesi Pharmaceuticals.

This video is approximately 54 minutes in length.

This presentation is sponsored by 

Speaker Information
Dabney Eidson BS, RRT-NPS  [ view bio ]
Pathophysiology and Assessment of Lung Cancer

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of lung cancer.

At the end of this presentation, the participant will be able to:

  1. Explain the pathophysiology of lung cancer
  2. Describe the methods of lung cancer diagnosis
  3. Identify treatment strategies for lung cancer
  4. Describe components of assessment for a patient with lung cancer

The presenter has no relationships to disclose.

This video is approximately 44 minutes in length.

This presentation is sponsored by 

Speaker Information
Albert Rizzo MD  [ view bio ]
Pathophysiology and Assessment of Interstitial Lung Disease

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of interstitial lung disease.

At the end of this presentation, the participant will be able to:

  1. Explain the pathophysiology of interstitial lung disease
  2. Describe the methods of interstitial lung disease
  3. Identify treatment strategies for interstitial lung disease
  4. Describe components of assessment for a patient with interstitial lung disease

The presenter has no relationships to disclose.

This video is approximately 27 minutes in length.

Speaker Information
Shawna Strickland PhD, RRT-NPS, RRT-ACCS, AE-C, FAARC  [ view bio ]
Pathophysiology and Assessment of Pulmonary Hypertension

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of pulmonary hypertension.

At the end of this presentation, the participant will be able to:

  1. Explain the pathophysiology of pulmonary hypertension
  2. Describe the methods of pulmonary hypertension diagnosis
  3. Identify treatment strategies for pulmonary hypertension
  4. Describe components of assessment for a patient with pulmonary hypertension

The presenter has no relationships to disclose.

This video is approximately 44 minutes in length.

This presentation is sponsored by 

Speaker Information
Martha Kingman DNP, FNP-C  [ view bio ]
Overview of Disease Management

This presentation will identify the key components to a comprehensive disease management program and discuss the necessary skills of an effective disease manager.

At the end of this presentation, the participant will be able to:

  1. Identify the key components to a comprehensive disease management program
  2. Describe the importance of and the barriers to patient self-management
  3. Identify the skills necessary to be an effective disease manager

The presenter has no relationships to disclose.

This video is approximately 54 minutes in length.

Speaker Information
Timothy Myers MBA, RRT-NPS, FAARC  [ view bio ]
Pulmonary Function Testing

This presentation will assist the participant in differentiating the various types of pulmonary function tests and their use among the disease processes discussed in the course as well as identifying disease severity based on pulmonary function test results.

At the end of this presentation, the participant will be able to:

  1. Define three types of pulmonary function tests
  2. Review reference equations/predicted values/lower limits of normal
  3. Describe quality testing criteria
  4. Describe and review lung volumes and capacities
  5. Identify specific pulmonary abnormalities with pulmonary function tests
  6. Identify disease severity with pulmonary function tests

The presenter has no relationships to disclose.

This video is approximately 47 minutes in length.

Speaker Information
Curt Merriman BA, RRT, CPFT  [ view bio ]
Pharmacologic Interventions

This presentation will discuss currently available pulmonary medications and their indications, delivery methods, and medication interaction.

At the end of this presentation, the participant will be able to:

  1. List currently available pulmonary medications
  2. Describe indications for various pulmonary medications based on scientific evidence and use in specific disease processes
  3. Determine appropriate delivery method for inhaled medications based on patient cognition, physical ability, and preference

The presenter has no relationships to disclose.

This video is approximately 1 hour and 23 minutes in length.

Speaker Information
Timothy Myers MBA, RRT-NPS, FAARC  [ view bio ]
Supplemental Oxygen Administration

This presentation will describe the physiologic benefit of supplemental oxygen while also assisting the health care professional in differentiating between home systems and determining the appropriate delivery system to meet patient need.

At the end of this presentation, the participant will be able to:

  1. Describe the physiological benefit of supplemental oxygen
  2. Differentiate between various home oxygen delivery systems
  3. Determine appropriate delivery system to meet patient need

The presenter has no relationships to disclose.

This video is approximately 37 minutes in length.

Speaker Information
Curt Merriman BA, RRT, CPFT  [ view bio ]
Tobacco Cessation

This presentation will explain the scientific factors supporting tobacco cessation, general approaches to smoking cessation, and pharmacologic agents in tobacco cessation programs.

At the end of this presentation, the participant will be able to:

  1. Explain the scientific factors supporting tobacco cessation
  2. Identify general approaches to smoking cessation
  3. Explain the pharmacologic agents employed in a tobacco cessation program.

The presenter has no relationships to disclose.

This video is approximately 23 minutes in length.

Speaker Information
Sarah Varekojis PhD, RRT, FAARC  [ view bio ]
Tobacco Cessation

This presentation will explain the barriers to smoking cessation, describe motivational interviewing, and demonstrate effective motivational interviewing skills.

At the end of this presentation, the participant will be able to:

  1. Identify the barriers to tobacco cessation
  2. Describe motivational interviewing
  3. Demonstrate effective motivational interviewing skills.

The presenter has no relationships to disclose.

This video is approximately 22 minutes in length.

Speaker Information
Sarah Varekojis PhD, RRT, FAARC  [ view bio ]
Respiratory Exacerbation Management

This presentation will assist the learner in identifying respiratory changes that indicate the presence of pulmonary disease exacerbation and determining appropriate interventions for various severity levels of exacerbations.

At the end of this presentation, the participant will be able to:

  1. Identify respiratory changes that indicate the presence of a pulmonary disease exacerbation
  2. Recognize the severity level of an exacerbation
  3. Determine appropriate interventions for various severity levels of exacerbations

The presenter has no relationships to disclose.

This video is approximately 27 minutes in length.

Speaker Information
Karen Gregory DNP, RRT, AE-C, FAARC  [ view bio ]
Pulmonary Disease and Nutrition: Basic Concepts

This presentation will discuss malnutrition in the context of pulmonary disease and developing nutrition strategies for patients with pulmonary disease.

At the end of this presentation, the participant will be able to:

  1. Describe the measurement of malnutrition
  2. Describe the effects of malnutrition on patients with pulmonary disease
  3. Develop a nutrition strategy for patients with pulmonary disease

The presenter has no relationships to disclose.

This video is approximately 24 minutes in length.

Speaker Information
Karen Gregory DNP, RRT, AE-C, FAARC  [ view bio ]
Lung Transplantation

This presentation will discuss the policies and regulations addressing lung transplantation and when the chronic pulmonary disease patient may qualify for lung transplantation in addition to pre- and post-lung transplantation patient care.

At the end of this presentation, the participant will be able to:

  1. Identify the qualifying measures for listing a patient for lung transplantation
  2. Discuss the self-management behaviors necessary for maintaining status on the transplantation list
  3. Discuss the challenges in adhering to a pre-lung transplantation program
  4. Identify the health behaviors necessary for wellness post-transplantation
  5. Discuss the role of the health care provider in assisting the patient post-transplant

The presenter has no relationships to disclose.

This video is approximately 19 minutes in length.

Speaker Information
David Mason MD  [ view bio ]
Palliative Care and Chronic Pulmonary Disease

This presentation will discuss palliative care throughout the spectrum of chronic pulmonary disease, beginning with diagnosis and progressing through end-of-life care.

At the end of this presentation, the participant will be able to:

  1. Differentiate between palliative care and hospice
  2. Identify appropriate timing to initiate hospice
  3. Discuss palliative care in the context of chronic lung disease 

The presenter has no relationships to disclose.

This video is approximately 23 minutes in length.

Speaker Information
Shawna Strickland PhD, RRT-NPS, RRT-ACCS, AE-C, FAARC  [ view bio ]
Pulmonary Rehabilitation

This presentation will define pulmonary rehabilitation and describe the essential components of a comprehensive pulmonary rehabilitation program.

At the end of this presentation, the participant will be able to:

  1. Define pulmonary rehabilitation
  2. Describe the essential components of a comprehensive pulmonary rehabilitation program
  3. Explain the benefits of pulmonary rehabilitation

The presenter has no relationships to disclose.

This video is approximately 1 hour and 13 minutes in length.

This presentation is sponsored by

Speaker Information
Trina Limberg BS, RRT, FAARC, MAACVPRT  [ view bio ]
Discharge Planning

This presentation will provide an overview of significant changes to Medicare's discharge planning process and highlight opportunities for healthcare providers to play a greater role in ensuring their patient's post-discharge care needs are identified.

At the end of this presentation, the participant will be able to:

  1. Name the 5 key standards in the Discharge Planning Hospital Conditions of Participation.
  2. Describe one or two elements of each standard.
  3. Name the Medicare requirements for reimbursement of commonly ordered respiratory DME.
  4. Describe key roles in improving transitions.

The presenter has no relationships to disclose.

This video is approximately 43 minutes in length.

Speaker Information
Krystal Craddock BS, RRT-NPS, CCM  [ view bio ]
Patient Education

This presentation will discuss the essential components of effective communication and patient education, including basic adult learning theory, barriers to learning, and transitional care.

At the end of this presentation, the participant will be able to:

  1. Identify essential components of effective communication and patient education
  2. Describe basic adult learning theory
  3. Identify barriers to learning
  4. Discuss issues with transitional care

The presenter has no relationships to disclose.

This video is approximately 43 minutes in length.

This presentation is sponsored by

Speaker Information
Tonya Winders MBA  [ view bio ]
Measurable Outcomes in a Chronic Pulmonary Disease Management Program

This presentation will discuss the importance of measuring outcomes to the success of the chronic disease management program. In addition, reimbursement and meaningful outcomes measures will be discussed.

At the end of this presentation, the participant will be able to:

  1. Discuss the importance of measuring outcomes to the success of the chronic disease management program
  2. Identify meaningful outcomes measures
  3. Discuss reimbursement

The presenter has no relationships to disclose.

This video is approximately 15 minutes in length.

Speaker Information
Sarah Varekojis PhD, RRT, FAARC  [ view bio ]
Individual topic purchase: Selected
American Association for Respiratory Care
Continuing Respiratory Care Education: 14.50
Products
Streaming
Complimentary: $0.00
: $0.00
Member: $240.00
Student: $240.00
Full Price: $290.00